Advertisement



Drug Recalls

Last updated

Every drug recall in FDA enforcement reports from the last three years, plus older recalls that are still open. Filter by severity, status or medicine, and check the lot numbers on your package.

0 Class I (most serious) drug recalls reported in the last 30 days.

3 recalls

  • Class II Terminated

    Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

    Reason: Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

    RemedyRepack Inc. · Phenazopyridine Hydrochloride

    Lots, distribution and details
    Lots / codes
    Lot # B2906961-042524, exp. date 02/26/2027
    Distribution
    Product was distributed to one medical facility.
    Quantity
    8 bottles
    Recall started
    May 31, 2024 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0549-2024
  • Class II Completed

    Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by: Winder Laboratories, LLC. 716 Patrick Industrial Lane, Winder, GA 30680, NDC 75826-114-10,

    Reason: Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

    Winder Laboratories, LLC · Phenazopyridine Hydrochloride

    Lots, distribution and details
    Lots / codes
    Lot#: 1142404 Exp. Date 02/27/2027
    Distribution
    Nationwide within the United States
    Quantity
    473 cases (5676 Bottles)
    Recall started
    May 28, 2024 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0545-2024
  • Class II Ongoing

    Phenobarbital 62. 5mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

    Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

    Lowlite Investments, Inc. D/B/A Olympia Pharmacy

    Lots, distribution and details
    Lots / codes
    B5128 Exp 8/28/13
    Distribution
    Nationwide and PR
    Quantity
    1
    Recall started
    May 29, 2013 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-769-2013

Have this medicine at home? Compare the lot number and expiry date on your package with the recall. Do not stop taking a prescribed medicine on your own — stopping suddenly can be riskier than the recalled lot. Your pharmacist can check it and usually swap it for an unaffected one.

What the recall classes mean

  • Class I Most serious: use could cause serious health problems or death.
  • Class II Could cause temporary or medically reversible health problems; serious harm is unlikely.
  • Class III Not likely to cause health problems — for example a labelling or packaging fault.

Source: FDA Enforcement Report, via openFDA. Updated here twice a day; last update October 31, 2026 14:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.

Advertisement